Effect of Orlistat on Fecal Fat, Fecal Biliary Acids, and Colonic Cell Proliferation in Obese Subjects

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 11, 2007, Pages 1291-1299

  Ahnen, Dennis J ^a   Guerciolini, Roberto ^b,c   Hauptman, Jonathan ^b   Blotner, Steven ^b   Woods, Cindy J ^d   Wargovich, Michael J ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c Sirna Therapeutics Inc   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; FECES LIPID; PLACEBO; TETRAHYDROLIPSTATIN;

ADULT; ARTICLE; BODY MASS; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTI-OBESITY AGENTS; BILE ACIDS AND SALTS; BIOPSY; BROMODEOXYURIDINE; CELL PROLIFERATION; COLON; DIET, FAT-RESTRICTED; DIETARY FATS; DOUBLE-BLIND METHOD; FATTY ACIDS; FECES; FEMALE; HUMANS; LACTONES; MALE; MIDDLE AGED; MITOTIC INDEX; OBESITY; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 35549005280     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.07.009     Document Type: Article

References (65)

1. Giovannucci E., and Willett W.C. Dietary factors and risk of colon cancer. Ann Med 26 (1994) 443-452
2. Potter J.D. Nutrition and colorectal cancer. Cancer Causes Control 7 (1996) 127-146
3. Trichopoulou A., and Lagiou P. Worldwide patterns of dietary lipids intake and health implications. Am J Clin Nutr 66 (1997) 961S-964S
4. Reddy B.S. Dietary fat and colon cancer: animal model studies. Lipids 27 (1992) 807-813
5. Hecht J.R. Dietary fat and colon cancer. Adv Exp Med Biol 399 (1996) 157-163
6. Newmark H.L., Wargovich M.J., and Bruce W.R. Colon cancer and dietary fat, phosphate and calcium: a hypothesis. J Natl Cancer Inst 72 (1984) 1323-1325
7. Pickering J.S., Lupton J.R., and Chapkin R.S. Dietary fat, fiber and carcinogen alter fecal diacylglycerol composition and mass. Cancer Res 55 (1995) 2293-2298
8. Orchel A., Dzierzewicz Z., Parfiniewicz B., et al. Butyrate-induced differentiation of colon cancer cells is PKC and JNK dependent. Dig Dis Sci 50 (2005) 490-498
9. Chapkin R.S., Jiang Y.H., Davidson L.A., et al. Modulation of intracellular second messengers by dietary fat during colonic tumor development. Adv Exp Med Biol 422 (1997) 85-96
10. Liu Y., Su W., Thompson E.A., et al. Protein kinase CbetaII regulates its own expression in rat intestinal epithelial cells and the colonic epithelium in vivo. J Biol Chem 279 (2004) 45556-45563
11. Murray N.R., Weems C., Chen L., et al. Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon carcinogenesis. J Cell Biol 157 (2002) 915-920
12. Giovannucci E., and Goldin B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr 66 Suppl 1 (1997) 1564S-1571S
13. Zhi J., Melia A.T., Gierciolini R., et al. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther 56 (1994) 82-85
14. Sjöström L., Rissanen A., Andersen T., et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 352 (1998) 167-172
15. Davidson M.H., Hauptmann J., DiGirolamo M., et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 281 (1999) 235-242
16. Toplak H., Ziegler O., Keller U., et al. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance. Diabetes Obes Metab 7 (2005) 699-708
17. Chaput J.P., St-Pierre S., and Tremblay A. Currently available drugs for the treatment of obesity: sibutramine and orlistat. Mini Rev Med Chem 7 (2007) 3-10
18. van de Kamer J.H., Ten Bokkel Huinink H., and Weijers H.A. Rapid method for the determination of fat in feces. J Biol Chem 177 (1949) 347-355
19. Schelkop G.M., and Milne D.B. Wet microwave digestion of diet and fecal samples for inductively coupled plasma analysis. Anal Chem 60 (1988) 2060-2062
20. Czubayko F., Beumers B., Lammsfuss S., et al. A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatients studies in humans. J Lipid Res 32 (1991) 1861-1867
21. Klurfeld D.M., and Bull A.W. Fatty acids and colon cancer in experimental models. Am J Clin Nutr 66 (1997) 1530S-1538S
22. Armstrong B., and Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15 (1975) 617-631
23. Howell M.A. Diet as an etiological factor in the development of cancers of the colon and rectum. J Chron Dis 28 (1975) 67-80
24. Satia-Abouta J., Galanko J.A., Martin C.F., et al. Food groups and colon cancer risk in African-Americans and Caucasians. Int J Cancer 109 (2004) 728-736
25. Jain M., Cook G.M., Davis F.G., et al. A case-control study of diet and colorectal cancer. Int J Cancer 26 (1980) 757-768
26. Potter J.D., and McMichael A.J. Diet and cancer of the colon and rectum: a case-control study. J Natl Cancer Inst 76 (1986) 557-569
27. Bristol J.B., Emmett P.M., Heaton K.W., et al. Sugar, fat, and the risk of colorectal cancer. BMJ 291 (1985) 1467-1470
28. Peters R.K., Pike M.G., Garabrandt D., et al. Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 3 (1992) 457-473
29. Howe G.R., Aronson K.J., Benito E., et al. The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control 8 (1997) 215-228
30. Willett W.C., Stampfer M.J., Colditz G.A., et al. Relation of meat, fat and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 323 (1990) 1664-1672
31. Bostick R.M., Potter J.D., Kushi L.H., et al. Sugar, meat and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5 (1994) 38-52
32. Goldbohm R.A., van den Brandt P.A., van't Veer P., et al. A prospective cohort study on the relation between meat consumption and the risk of colon cancer. Cancer Res 54 (1994) 718-723
33. Giovannucci E., Rimm E.B., Stampfer M.J., et al. Intake of fat, meat and fiber in relation to risk of colon cancer in men. Cancer Res 54 (1994) 2390-2397
34. Kato I., Akhmedkhanov A., Koenig K., et al. Prospective study of diet and female colorectal cancer: the New York University Women's Health Study. Nutr Cancer 28 (1997) 276-281
35. Schatzkin A., Lanza E., Corle D., et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 342 (2000) 1149-1155
36. MacLennan R., Macrae F., Bain C., et al. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J Natl Cancer Inst 87 (1995) 1760-1766
37. Deschner E.E., Cohen B.I., and Raicht R.F. Acute and chronic effect of dietary cholic acid on colonic epithelial cell proliferation. Digestion 21 (1981) 290-296
38. Bull A.W., Marnett L.J., Dawe E.J., et al. Stimulation of deoxythymidine incorporation in the colon of rats treated intrarectally with bile acids and fats. Carcinogenesis 4 (1983) 207-210
39. DeRubertis F.R., and Craven P.A. Bile salt stimulation of colonic epithelial cell proliferation. J Clin Invest 74 (1984) 1614-1624
40. Lapré J.A., and Van der Meer R. Diet-induced increase of colonic bile acids stimulates lytic activity of fecal water and proliferation of colonic cells. Carcinogenesis 13 (1992) 41-44
41. Stadler J., Stern H.S., Sing Yeung K.A., et al. Effect of high fat consumption on cell proliferation activity of colorectal mucosa and on soluble fecal bile acids. Gut 29 (1988) 1326-1331
42. Imray C.H., Radley S., Davis A., et al. Fecal unconjugated bile acids in patients with colorectal cancer or polyps. Gut 33 (1992) 1239-1245
43. Kishida T., Taguchi F., Feng L., et al. Analysis of bile acids in colon residual liquid or fecal material in patients with colorectal neoplasia and control subjects. J Gastroenterol 32 (1997) 306-311
44. Guerciolini R. Mode of action of orlistat. Int J Obes 21 Suppl 3 (1997) S12-S23
45. Van Gaal L.F., Broom J.I., Enzi G., et al. Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Eur J Clin Pharmacol 54 (1998) 25-32
46. Stadler J., Stern H.S., Yeung K.S., et al. Effect of high fat consumption on cell proliferation activity of colorectal mucosa and on soluble fecal bile acids. Gut 29 (1998) 1326-1331
47. Wargovich M.J., Eng V.W.S., Newmark H.L., et al. Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium. Carcinogenesis 4 (1983) 1205-1207
48. Trouillot T.E., Pace D.G., Mckinley C., et al. Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss. Am J Gastroenterol 96 (2001) 1888-1894
49. Li Z., Maglione M., Tu W., et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 7 (2005) 532-546
50. Lim C.C., Ferguson L.R., and Tannock G.W. Dietary fibres as "prebiotics": implications for colorectal cancer. Mol Nutr Food Res 49 (2005) 609-619
51. Rafter J.J., Eng V.W., Furrer R., et al. Effects of calcium and pH on the mucosal damage produced by deoxycholic acid in the rat colon. Gut 27 (1986) 1320-1329
52. Garland C., Shekele R.B., and Barrett-Connor E. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1 (1985) 307-309
53. Walker A.R.P., and Walker A.J. Fecal pH, dietary fiber intake, and proneness to colon cancer in four South African populations. Br J Cancer 53 (1986) 489-495
54. Wargovich M.J., Eng V.W.S., and Newmark H.L. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett 23 (1984) 253-258
55. Lipkin M. Biomarkers of increased susceptibility to gastrointestinal cancer: a new application to studies of cancer prevention in human subjects. Cancer Res 48 (1988) 235-245
56. Wargovich M.J., Isbell G., Shabot M., et al. Calcium supplementation decreases rectal epithelial cell proliferation in subjects with sporadic adenoma. Gastroenterology 103 (1992) 92-97
57. Steinbach G., Lupton J., Reddy B.S., et al. Effect of calcium supplementation on rectal epithelial hyperproliferation in intestinal bypass subjects. Gastroenterology 106 (1994) 1162-1167
58. Lupton J.R., Steinbach G., and Chang W.C. Calcium supplementation modifies the relative amounts of bile acids in bile and affects key aspects of human colon physiology. J Nutr 126 (1996) 1421-1428
59. Weisgerber U.M., Boeing H., Nemitz R., et al. Proliferation cell nuclear antigen (clone 19A2) correlated with 5-bromo-2-deoxyuridine labelling in human colonic epithelium. Gut 34 (1993) 1587-1592
60. Pohl A., Weyant J., and Ahnen D.J. Validation of the whole crypt mitotic count (WCMC) as a measure of proliferation in the rat colon. Gastroenterology 102 (1992) A939
61. Murray S.C., Sandler R.S., Keku T.O., et al. Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection. Cancer Epidemiol Biomarkers Prev 4 (1995) 715-720
62. Giovannuci E., Ascherio A., Rimm E.B., et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 6 (1995) 30-36
63. Pischon T., Lahmann P.H., Boeing H., et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98 (2006) 920-931
64. Calle E.E., Rodriguez C., Walker-Thurmond K., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003) 1625-1638
65. Kridel S.J., Axelrod F., Rozenkrantz N., et al. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res 64 (2004) 2070-2075